Drugs / Carenoprazan
Carenoprazan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05050188 | Jun → Sep 2021 | esophagitis | Jiangsu Carephar Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Carenoprazan | “Multiple Oral Doses of H008 (Carenoprazan Hydrochloride Tablets)” NCT05050188 ↗ |
| Known as | Carenoprazan Hydrochloride | “Multiple Oral Doses of H008 (Carenoprazan Hydrochloride Tablets)” NCT05050188 ↗ |
| Known as | H008 | “Multiple Oral Doses of H008 (Carenoprazan Hydrochloride Tablets)” NCT05050188 ↗ |